Anavex Life Sciences Corp

Market Cap

$276M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$2.57-$1.11 (-30.16%)

Jun 5, 2026

52W High $13.4152W Low $2.57

Company Details

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, includ...

CEO

—

IPO Date

Aug 2, 2006

Website

www.anavex.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$40M

EPS (Diluted)

Free Cash Flow

-$34M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

Feb 9, 2026

FY 2025

Nov 25, 2025

Q4 2025

Nov 25, 2025

Q3 2025

Aug 12, 2025

Q2 2025

May 13, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee